Keyphrases
C-erbB
100%
ErbB Receptors
80%
Ovarian Cancer
80%
Oncogene
80%
ErbB
80%
Soluble Form
40%
Soluble Receptor
30%
Ovarian Tumor
20%
Serum Samples
20%
Immunohistochemical Analysis
20%
Prognostic Indicator
20%
Advanced Ovarian Cancer
20%
Clinical Utility
20%
Therapeutic Approaches
20%
Ovarian Carcinoma Cells
20%
Tumor Samples
20%
Clinical Parameters
20%
Growth in Vitro
20%
Histologic
20%
Ovarian Carcinoma
20%
Breast Carcinoma
20%
ErbB3
20%
Cell Growth
20%
Expression Pattern
20%
Serum Levels
20%
C-erbB-2
20%
Future Therapeutics
5%
Tumor Cells
5%
Large Cohort
5%
Ovarian Carcinogenesis
5%
Truncated Forms
5%
Disease Activity
5%
Medicine and Dentistry
Proto Oncogene
100%
Ovarian Cancer
100%
Epidermal Growth Factor Receptor
100%
Cell Oncogene
50%
Krukenberg Tumor
50%
Receptor
30%
Neoplasm
25%
Cell Growth
25%
Ovarian Tumor
25%
In Vitro
25%
Carcinoma Cell
25%
Breast Carcinoma
25%
Disease Activity
5%
Tumor Cell
5%
Carcinogenesis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Epidermal Growth Factor Receptor
100%
Ovary Carcinoma
93%
Neoplasm
53%
Receptor
53%
Breast Carcinoma
46%
Ovary Tumor
46%
Disease Activity
6%
Carcinogenesis
6%